Sheena Sahota, M.D.

Mary Robinson

Dr. Sheena Sahota is originally from Missouri. She is a medical oncologist and hematologist. She is board certified in internal medicine, nephrology, hematology and oncology. She went to medical school at the University of Missouri-Kansas City where she completed the six year BA/MD program. From there she slowly made her way east through her various trainings including completing her internal …

Elena Garralda, M.D.

Mary Robinson

Dr. Garralda is a medical oncologist and clinical investigator who focuses her research on targeted agents, early drug development, translational research, and immunotherapies. She received her medical degree from the Universidad Autónoma de Madrid and completed her medical oncology specialization at the Hospital Universitario Madrid. Dr. Garralda also earned a Master’s degree in molecular oncology from the Centro de Estudios …

Josep Tabernero, M.D., PhD, MSc

Mary Robinson

Dr. Josep Tabernero, who founded the IOB Institute of Oncology in Barcelona, coordinates both units. NEXT Oncology – Barcelona is in the Hospital Quirónsalud Barcelona and headed by site coordinator Dr. Elena Garralda. The opening of the two units boosts continued research activity and creates a great opportunity to promote clinical research in Spain. Josep Tabernero holds MD and PhD …

Edwin Bellido, M.D.

Mary Robinson

Edwin Bellido, MD, MSc, is a Medical Oncologist and Clinical Investigator in the NEXT Oncology Early Drug Development Unit at Hospital Universitario Quirónsalud Madrid. Edwin Bellido, received his medical degree from the Public University of Cusco in Peru, in the upper third, and immediately after completed a master’s degree in research methodology in the area of health at the University of …

Jesús Fuentes Antrás , M.D.

Mary Robinson

Jesús Fuentes Antrás, MD, MSc, is a Medical Oncologist and Clinical Investigator in the NEXT Oncology Early Drug Development Unit at Hospital Universitario Quirónsalud Madrid. Dr. Fuentes Antrás received his MD with honors in 2015 from the Universidad Autónoma de Madrid. He completed his Medical Oncology training at Hospital Clínico San Carlos in Madrid, and subsequently joined the Drug Development and …